Bao Xingjun, Dong Wen, Wang Jipeng, Sun Fengze, Yao Huibao, Wang Di, Zhou Zhongbao, Wu Jitao
Second Clinical Medical College, Binzhou Medical University, Yantai, China.
Department of Urology, The Affiliated Yantai Yuhuangding Hospital of Qingdao University, Yantai, China.
Int J Urol. 2022 Oct;29(10):1188-1194. doi: 10.1111/iju.14968. Epub 2022 Jun 28.
To determine whether robot-assisted laparoscopic partial nephrectomy (RALPN) can benefit patients in terms of functional recovery in the treatment of renal hilar tumors compared to conventional laparoscopic partial nephrectomy (CLPN).
Between January 2019 and July 2021, patients with hilar tumors who underwent partial nephrectomy (PN) were acquired at our center and were classified into RALPN and CLPN groups. Ipsilateral parenchymal volume (IPV) and glomerular filtration rate (GFR) were determined independently 3-5 days before and 3 months after PN using contrast-enhanced computed tomography and nuclear renal scans. Pearson correlation was used to determine the link between ipsilateral GFR preservation and IPV preserved. Concurrently, multivariable analysis was employed to determine characteristics associated with functional recovery.
A total of 96 patients with hilar tumors were studied, of which 41 received RALPN and 55 received CLPN. Excisional parenchymal volume was 27 and 37 cm (p = 0.005) in RALPN and CLPN groups, respectively, and IPV preserved was 77% and 68% (p < 0.001). Furthermore, the ipsilateral GFR preserved was 77.7% and 75.3%, respectively (p = 0.003). On Pearson correlation, ipsilateral GFR preservation was linked with IPV preserved (r = 0.36, p < 0.001). According to a multivariate study, baseline GFR, IPV preserved, and surgical procedures (RALPN vs. CLPN) were significant factors influencing functional recovery.
Our study suggests that RALPN, rather than CLPN, can achieve better functional recovery in the treatment of hilar tumors due to its ability to win more IPV preserved. RALPN should be recommended as the first-line treatment for hilar tumors, but randomized controlled trials are required to validate our findings.
确定与传统腹腔镜部分肾切除术(CLPN)相比,机器人辅助腹腔镜部分肾切除术(RALPN)在治疗肾门肿瘤时能否使患者在功能恢复方面获益。
2019年1月至2021年7月,在我们中心收集接受部分肾切除术(PN)的肾门肿瘤患者,并分为RALPN组和CLPN组。在PN术前3 - 5天和术后3个月,分别使用对比增强计算机断层扫描和核肾扫描独立测定患侧实质体积(IPV)和肾小球滤过率(GFR)。采用Pearson相关性分析确定患侧GFR保留与IPV保留之间的联系。同时,采用多变量分析确定与功能恢复相关的特征。
共研究了96例肾门肿瘤患者,其中41例接受RALPN,55例接受CLPN。RALPN组和CLPN组的切除实质体积分别为27和37 cm³(p = 0.005),保留的IPV分别为77%和68%(p < 0.001)。此外,患侧保留的GFR分别为77.7%和75.3%(p = 0.003)。Pearson相关性分析显示,患侧GFR保留与IPV保留相关(r = 0.36,p < 0.001)。多变量研究表明,基线GFR、保留的IPV和手术方式(RALPN与CLPN)是影响功能恢复的重要因素。
我们的研究表明,由于RALPN能够保留更多的IPV,在治疗肾门肿瘤时比CLPN能实现更好的功能恢复。RALPN应被推荐为肾门肿瘤的一线治疗方法,但需要随机对照试验来验证我们的发现。